The current valuation score of Evaxion Biotech A/S is 6.49, ranking 318 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -15.38, which is -99.20% below the recent high of -0.12 and -40.36% above the recent low of -21.59.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.